MSL
ANAB icon

Mackay Shields LLC’s AnaptysBio ANAB Stock Holding History

Mackay Shields LLC’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27,527
Closed -$963K – 1350
2019
Q3 		$963K Buy
27,527
+2,800
+11% +$133K 0.01% 1115
2019
Q2 		$1.4M Buy
24,727
+15,931
+181% +$1.15M 0.01% 1037
2019
Q1 		$642K Buy
8,796
+1,300
+17% +$89.7K ﹤0.01% 1120
2018
Q4 		$478K Buy
+7,496
New +$557K ﹤0.01% 1153
2018
Q3 		– Sell
-7,100
Closed -$504K – 1125
2018
Q2 		$504K Hold
7,100
– – ﹤0.01% 1101
2018
Q1 		$739K Buy
+7,100
New +$800K ﹤0.01% 1055

Other funds holding ANAB

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Mackay Shields LLC's ANAB Position: Q4 2019 in Review

Mackay Shields LLC sold out of AnaptysBio (ANAB) in Q4 2019, closing a stake of 27,527 shares — an estimated $963K sold.

Mackay Shields LLC first reported a position in ANAB in Q1 2018 and held it in 6 quarters. The position peaked at $1.4M in Q2 2019. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

  • Mackay Shields LLC reported no remaining AnaptysBio position as of Q4 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 27,527 AnaptysBio shares in Q4 2019, an estimated $963K.
  • Mackay Shields LLC first reported a position in AnaptysBio in Q1 2018 and held it in 6 quarters.
  • Mackay Shields LLC's AnaptysBio position peaked at $1.4M in Q2 2019.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Mackay Shields LLC's 13F filing for Q4 2019, filed 11 Feb 2020.